Anti-HIV Drugs Cause Mitochondrial Dysfunction in Monocyte-Derived Macrophages | Zendy

Jennillee Wallace | Zendy; Hemil Gonzalez | Zendy; Reshma Rajan | Zendy; Srinivas D. Narasipura | Zendy; Amber K. Virdi | Zendy; Arnold Z. Olali | Zendy; Ankur Naqib | Zendy; Zarema Arbieva | Zendy; Mark MaienscheinCline | Zendy; Lena AlHarthi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Anti-HIV Drugs Cause Mitochondrial Dysfunction in Monocyte-Derived Macrophages

Author(s) -

Jennillee Wallace,

Hemil Gonzalez,

Reshma Rajan,

Srinivas D. Narasipura,

Amber K. Virdi,

Arnold Z. Olali,

Ankur Naqib,

Zarema Arbieva,

Mark MaienscheinCline,

Lena AlHarthi

Publication year - 2022

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.01941-21

Subject(s) - cart , efavirenz , immunology , abacavir , transcriptome , medicine , inflammation , immune system , immune dysregulation , phenotype , population , biology , bioinformatics , antiretroviral therapy , viral load , human immunodeficiency virus (hiv) , gene , genetics , gene expression , mechanical engineering , environmental health , engineering

Combination antiretroviral therapy (cART) dramatically changed the face of the HIV/AIDS pandemic, making it one of the most prominent medical breakthroughs of the past 3 decades. However, as the life span of persons living with HIV (PLWH) continues to approach that of the general population, the same cannot be said regarding their quality of life.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research